Gitnux/Report 2026

Herbal Industry Statistics

The global herbal medicine market is projected at $271.14 billion in 2026, explore figures behind growth, companies, and evidence and quality risks.
20Statistics
31Sources
4Sections
1Visuals
15mRead
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 32 days

01 Industry overview

The herbal industry at a glance

The global herbal medicine market is projected at $271.14 billion in 2026, while U.S. herbal supplement sales reached a record $13.23 billion in 2024, reflecting sustained demand for plant-based health products.

$271.14B[12]
Global market estimate, 2026
8.37%[12]
Global CAGR, 2026–2034
44.29%[12]
Europe market share, 2025
$13.23B[9]
U.S. supplement sales, 2024
Market size
The global herbal medicine market was valued at $251.24 billion in 2025 and is projected to reach $271.14 billion in 2026. U.S. herbal supplement sales totaled $13.23 billion in 2024, the latest available annual U.S. retail figure.[12][9]
Forecast & CAGR
The global herbal medicine market is forecast to grow from $271.14 billion in 2026 to $515.92 billion by 2034, representing an 8.37% CAGR. A separate 2026 estimate places the herbal supplements market at $54.85 billion, with a 9.02% CAGR through 2034.[12]
Market share & regions
Europe accounted for 44.29% of the global herbal medicine market in 2025, according to Fortune Business Insights. In the herbal supplements segment, North America held the largest regional share at 37% in 2025.[12]
Segmentation
Herbal medicine products are segmented by form, including powders, liquids and gels, and tablets and capsules; by application, including pharmaceuticals and nutraceuticals, food and beverages, and personal care; and by distribution channel, including retail, pharmacies and online platforms. In U.S. herbal supplements, combination formulas represented 49.7% of sales in 2024, compared with 50.3% for single-herb products.[12][2]
Key players & concentration
Public market reports identify large multinational supplement, pharmaceutical and consumer-health companies alongside specialized botanical suppliers, but do not provide a consistent global concentration ratio. In the U.S. mainstream channel, the leading herbal ingredients in 2024 were psyllium at $289.5 million, elderberry at $145.2 million and ashwagandha at $144.5 million.[9]
Trends, drivers & challenges
Demand is supported by consumer preference for natural remedies, preventive healthcare and traditional medicine systems such as Ayurveda and Traditional Chinese Medicine. Key challenges include inconsistent evidence standards, adulteration and quality control, while climate stress is affecting some botanical supply chains; an April 2026 report described drought risks for myrrh production in East Africa.[12][13][14]
Consumer behavior & competition
U.S. herbal supplement sales increased 5.4% in 2024, with consumers showing strong demand for products associated with cardiovascular, cognitive and general wellness benefits. Psyllium led the mainstream channel at $289.5 million, while ingredient competition includes elderberry, ashwagandha, turmeric and beet root.[9][15]
M&A
M&A activity continued in botanical ingredients and herbal supplements in 2026: Monterey Bay Herb Co. acquired NP Nutra in March, creating a combined portfolio of more than 1,000 products. Kokusai Naturista acquired Flora Health in July 2026, adding herbal supplement manufacturing and distribution assets.[16][17]
Regulation
WHO reported that 124 Member States had laws or regulations for herbal medicines in 2023, while 124 of 176 responding Member States reported registration or licensing systems. In the United States, FDA generally does not preapprove dietary supplements; manufacturers are responsible for safety, labeling and compliance, with new dietary ingredients generally requiring notification at least 75 days before marketing.[13][18][10]
Latest news
In September 2026, FDA sought public input on barriers to developing botanical drug products and announced a joint FDA–European Medicines Agency workshop on herbal medicinal and botanical drug regulation. The WHO global report on traditional, complementary and integrative medicine was published on December 20, 2025 and includes updated information on national herbal-medicine policies and regulation.[10][13]

02 Ranking

Top 10 Companies in the Herbal Industry

The leading companies in the herbal industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 21, 2026 · Next review December 21, 2026

Verdict

TSUMURA stands out for Kampo formulations because it reports an 18.29% operating margin, while Schwabe Group focuses on plant-based phytopharmaceuticals since all group companies base pharmaceuticals and health products on plants.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in kampo formulations

    TSUMURA

    JP

    Ranked #1 · 9.3 · Kampo formulations

    Why we picked it: It produces Kampo extract intermediates and sells granular Kampo formulations, with a reported operating margin of an 18.29%.

  2. Leader in plant-based phytopharmaceuticals

    Schwabe Group

    DE

    Ranked #2 · 9.1 · Plant-based phytopharmaceuticals

    Why we picked it: All group companies base pharmaceuticals and health products on plants, aligning its offerings across phytopharmaceuticals and herbal health.

  3. Leader in dietary supplements

    NOW Health Group

    US

    Ranked #3 · 8.9 · Dietary supplements

    Why we picked it: It manufactures more than 1,500 dietary supplements and natural products, sold in over 100 countries, including essential oils.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the herbal industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

TSUMURA

Kampo formulations · JP

9.3
2

Schwabe Group

Plant-based phytopharmaceuticals · DE

9.1
3

NOW Health Group

Dietary supplements · US

8.9
4

Dabur India

Ayurvedic consumer health · IN

8.7
5

Himalaya Wellness

Herbal personal care · IN

8.7
6

Ricola Group

Herbal drops and specialty teas · CH

8.6
7

Weleda

Natural cosmetics and plant-based medicines · CH

8.5
8

LIPTON Teas and Infusions

Tea and herbal infusions across global markets · NL

8.5
9

Yunnan Baiyao Group

Traditional Chinese medicine and herbal health products · CN

8.0
10

Patanjali Ayurved

Ayurvedic, herbal health and consumer products · IN

7.8

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 21, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 21). Top 10 companies in the herbal industry. In Herbal Industry Statistics. Gitnux. https://gitnux.org/herbal-industry-statistics/#top-companies

report visual · Projection

Total US retail sales of herbal supplements, all retail channels

Total US retail sales of herbal supplements, all retail channels grew from $8.8B in 2018 to $12.6B in 2023.

$8.8B
Start
+7.41%
CAGR · 5y
$12.5B
Projected
20182023
source-verifiedumb.herbalgram.org2023

04 Statistics

Market Intelligence

Market intelligence ties category demand to scale: $271.14 billion in 2026 global herbal medicine and $13.23 billion in 2024 U.S. herbal-supplement retail sales.

Market size, volume and shipments in the herbal industry

  • $58.6155 billion was the global herbal-medicine market value in 2023; measure is monetary market value covering herbal products across the reported countries and regions.[1]
  • $13.23 billion in U.S. herbal-supplement retail sales in 2024; scope covers supplements whose primary functional ingredient is herbal or fungal, excluding herbal teas, conventional foods and cosmetics.[2]
  • $42.3 billion was the global herbal-supplements market value in 2024; category includes herbal supplements segmented by product, formulation, consumer, distribution channel and region.[3]

Forecast growth and shipments in the herbal industry

  • Global herbal-supplements revenue is projected to grow from $53.25 billion in 2025 to $74.26 billion in 2030, at a 6.9% CAGR during 2026–2030.[4]
  • Global herbal-supplements revenue is projected to rise from $54.23 billion in 2025 to $75.41 billion in 2031, a 5.75% CAGR during 2026–2031; category is herbal supplements.[5]
  • Global herbal-supplements revenue is projected to reach $90.2 billion in 2033, expanding at an 8.9% CAGR from 2025–2033; category covers supplements by product, formulation, consumer, channel and region.[3]

05 Statistics

Production & Operations

Production and operations show measurable quality risk, including 56.7% adulteration among 533 ginkgo products and 27.3% adulterated or mislabeled botanical samples across 78 publications.

Defects and conformance in the herbal industry

  • 38% of online Ayurvedic herbal-supplement listings contained disease claims in a U.S. study of products associated with purported COVID-19 treatment.[6]
  • 56.7% of 533 commercial ginkgo products were adulterated, the highest rate among five selected botanicals in a global literature review.[7]
  • 818 of 2,995 botanical samples (27.3%) were adulterated or mislabeled across 78 publications covering global commercial herbal products and ingredients reviewed through 2023.[7]

06 Statistics

Customers & Channel

Customer and channel data show channel mix shifts: 74.1% of U.S. herbal/traditional-product sales used pharmacies in 2022 and 6.3% came through retail e-commerce.

Distribution channels for herbal

  • 74.1% of U.S. herbal/traditional-product sales used pharmacies in 2022; grocery retailers accounted for 11.4%, direct selling 5.1% and retail e-commerce 6.3%.[8]
  • 56.7% of U.S. herbal-supplement retail sales came through NBJ’s direct-sales channel in 2024, up from 48.6% in 2015; direct sales include internet, direct-response media, practitioners and multilevel marketing.[9]
  • $2.607 billion in U.S. herbal-supplement sales came through the mass-market retail channel in 2024, up 4.9% from 2023, according to Nutrition Business Journal.[9]

07 Statistics

Regulation & Risk

Regulation and risk emphasize compliance timelines and incident outcomes, including a 75-day new dietary ingredient notification period and a recall that reached 90 units in January 2026.

Regulations and compliance for herbal

  • 15 business days is the statutory deadline for submitting serious adverse-event reports to FDA after receipt under FD&C Act §761(c), covering U.S. herbal dietary supplement manufacturers, packers and distributors.[10]
  • 1 year is the required follow-up reporting window for new medical information after an initial serious adverse-event report under FD&C Act §761(c)(2), covering U.S. herbal dietary supplement responsible persons.[10]
  • 6 years is the required record-retention period for later-received adverse-event information under FD&C Act §761(e)(1), covering U.S. herbal dietary supplement manufacturers, packers and distributors.[10]
  • 75 days is the required premarket notification period for a new dietary ingredient before interstate commerce under FD&C Act §413(a)(2) and 21 CFR 190.6(a), covering U.S. herbal dietary supplements containing an NDI.[10]

Recalls and safety notices for herbal

  • 12 product and supply-chain samples tested positive for Salmonella during the U.S. investigation of the 2025–2026 moringa dietary-supplement outbreak.[11]
  • 90 units were recalled nationwide in January 2026 after routine inspection found undeclared wheat in two HerbsForever herbal dietary supplements: 45 Hingwastik units and 45 Gastro Care units.[10]
  • 131 illness cases, 36 hospitalizations and zero deaths were linked to recalled moringa-leaf dietary supplements across 38 U.S. states in the final 2025–2026 Salmonella outbreak investigation.[10]
  • 11 people in 7 U.S. states became ill and 3 were hospitalized in the October 2025 Salmonella outbreak linked to moringa-containing powdered supplements; no deaths were reported.[11]

Key questions about the herbal industry

What is the global herbal medicine market size in 2026?
The global herbal medicine market is projected at $271.14 billion in 2026. The estimate also places it at $251.24 billion in 2025.
How fast is the global herbal medicine market growing from 2026 to 2034?
The global herbal medicine market has an 8.37% CAGR for 2026–2034. It is forecast to reach $515.92 billion by 2034 from $271.14 billion in 2026.
Which companies lead the herbal industry?
TSUMURA stands out for Kampo formulations because it reports an 18.29% operating margin, while Schwabe Group focuses on plant-based phytopharmaceuticals since all group companies base pharmaceuticals and health products on plants.
What technology and evidence practices are changing in herbal products?
Evidence standards and quality controls are under pressure, with adulteration and quality issues documented through 2023. U.S. regulatory timelines also set operational deadlines for adverse-event reporting and new ingredient notifications.
How concentrated is the herbal market structure across regions and channels?
Fortune Business Insights places Europe at 44.29% of the global herbal medicine market in 2025. In the U.S., NBJ reports 56.7% of herbal-supplement retail sales in 2024 came through its direct-sales channel.
What regulatory timelines matter for U.S. herbal dietary supplement adverse events and new ingredients?
Serious adverse-event reports must be submitted within 15 business days after receipt. New dietary ingredients require a 75-day premarket notification period before interstate commerce.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 21). Herbal Industry Statistics. Gitnux. https://gitnux.org/herbal-industry-statistics
MLA
Samuel Norberg. "Herbal Industry Statistics." Gitnux, 21 Nov 2026, https://gitnux.org/herbal-industry-statistics.
Chicago
Samuel Norberg. 2026. "Herbal Industry Statistics." Gitnux. https://gitnux.org/herbal-industry-statistics.